Real-time enrollment status for this acinetobacter baumannii-calcoaceticus complex infection (abc) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:42 AM UTC
| NCT Number | NCT06746883 |
| Recruiting Status | Recruiting |
| Condition | Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC) |
| Phase | Clinical Trial |
| Target Enrollment | 100 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Innoviva Specialty Therapeutics |
| Last Updated on CT.gov | June 24, 2026 (2 weeks ago) |
As of July 13, 2026: Clinical trial NCT06746883 is currently recruiting participants. This clinical trial study for acinetobacter baumannii-calcoaceticus complex infection (abc) is actively seeking new participants at 12 locations across the United States. The study is sponsored by Innoviva Specialty Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06746883 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06746883 was last updated 2 weeks ago (June 24, 2026). HelloStudys verifies this status automatically.